Simone Giuliano
Udine, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Emergent Sulbactam-Durlobactam Non-Susceptibility in Acinetobacter baumannii: Potential Interplay Between PBP3 and AdeFGH Overexpression.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 28, 2026
Case Commentary: When susceptibility is not enough in recurrent Burkholderia cenocepacia infection.
Journal: Antimicrobial agents and chemotherapy
Published: May 28, 2026
Precision Redosing of Oritavancin: A Population Pharmacokinetic Framework to Optimize Long-Term Therapy for Complex Gram-Positive Infections.
Journal: International journal of antimicrobial agents
Published: May 13, 2026
Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring.
Journal: JAC-antimicrobial resistance
Published: March 20, 2026
Current opinion on the potential role of liposomal amphotericin B in underexplored clinical scenarios.
Journal: Clinical microbiology reviews
Published: March 13, 2026
Optimizing dalbavancin dosing for complicated methicillin-resistant Staphylococcus aureus infections: a multicentre population pharmacokinetic study.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: March 04, 2026
A comparative evaluation of aztreonam-avibactam and ceftazidime-avibactam plus aztreonam for infections due to MBL-producing Enterobacterales.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 02, 2026
Does acute pyelonephritis skew outcomes in registrational trials of novel antibiotics for complicated urinary tract infections? A systematic review and meta-analysis.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 24, 2026
Emergence of dalbavancin non-susceptible methicillin-resistant Staphylococcus epidermidis (MRSE) in a patient treated with dalbavancin prolonged therapy: Case report, therapeutic drug monitoring and genomic characterization.
Journal: International journal of antimicrobial agents
Published: February 24, 2026
Real-World Experience on the Use of Eravacycline at Doses of 1 mg/kg Bodyweight and Fixed Dose Strategy in Two European Tertiary Centers.
Journal: Antibiotics (Basel, Switzerland)
Published: February 22, 2026
Optimizing target inactivation to treat multidrug-resistant Escherichia coli with NDM and PBP3 mutations: "going the extra mile".
Journal: Antimicrobial agents and chemotherapy
Published: February 20, 2026
Genome sequence of a methicillin-resistant Staphylococcus epidermidis (MRSE) resistant to dalbavancin and teicoplanin isolated in Italy, 2023.
Journal: Journal of global antimicrobial resistance
Published: February 03, 2026
Last Updated: 09/26/2026